Marie-Edith Bonneterre

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

F. Mornex, L. Thomas, Peter Mohr et al. · Melanoma Research · 2003 · 152 citations

Surgical Oncology, Melanoma Cerebral Metastases, Malignant Melanoma +16

Prognostic factors among cancer patients with good performance status screened for phase I trials

Nicolas Penel, Marie Vanseymortier, Marie-Edith Bonneterre et al. · Investigational New Drugs · 2007 · 55 citations

Prognostic Factors, Prognostic Evaluation, Good Performance Status +13

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

Nicolas Penel, Jean‐Pierre Delord, Marie-Edith Bonneterre et al. · Investigational New Drugs · 2009 · 30 citations

Prognostic Evaluation, Medicine, Prognosis +10

Phase I Combining a P-Glycoprotein Inhibitor, MS209, in Combination with Docetaxel in Patients with Advanced Malignancies

Véronique Dièras, Jacques Bonneterre, Valérie Laurence et al. · Clinical Cancer Research · 2005 · 25 citations · Full text

Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)

Iulia Peciu-Florianu, Quentin Vannod‐Michel, Enora Vauleon et al. · Journal of Neuro-Oncology · 2024 · 20 citations · Full text